Gyroscope Capital Management Group’s AbbVie ABBV Stock Holding History

Gyroscope Capital Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	$5.22M	Buy	34,989 +2,825	+9%	+$421K	1.2%	28
2023 Q2	$4.33M	Buy	32,164 +167	+0.5%	+$22.5K	1%	34
2023 Q1	$5.1M	Buy	31,997 +86	+0.3%	+$13.7K	1.3%	27
2022 Q4	$5.16M	Buy	+31,911	New	+$5.16M	1.56%	26
2022 Q3	–	Sell	-20,000	Closed	-$3.06M	–	116
2022 Q2	$3.06M	Hold	20,000	–	–	1.05%	33
2022 Q1	$3.24M	Sell	20,000 -1,900	-9%	-$308K	1.11%	31
2021 Q4	$2.97M	Hold	21,900	–	–	1.04%	30
2021 Q3	$2.36M	Hold	21,900	–	–	0.89%	30
2021 Q2	$2.47M	Hold	21,900	–	–	0.87%	30
2021 Q1	$2.37M	Sell	21,900 -1,135	-5%	-$123K	0.95%	28
2020 Q4	$2.47M	Buy	23,035 +3,432	+18%	+$368K	1.06%	28
2020 Q3	$1.72M	Sell	19,603 -5,371	-22%	-$470K	0.78%	31
2020 Q2	$2.45M	Buy	24,974 +5,974	+31%	+$587K	1.11%	26
2020 Q1	$1.45M	Hold	19,000	–	–	0.68%	31
2019 Q4	$1.68M	Sell	19,000 -473	-2%	-$41.9K	0.61%	33
2019 Q3	$1.44M	Hold	19,473	–	–	0.57%	36
2019 Q2	$1.42M	Hold	19,473	–	–	0.54%	39
2019 Q1	$1.58M	Sell	19,473 -11,450	-37%	-$928K	0.6%	34
2018 Q4	$2.85M	Buy	+30,923	New	+$2.85M	1.09%	27
2018 Q3	–	Sell	-68,271	Closed	-$6.33M	–	113
2018 Q2	$6.33M	Buy	68,271 +3,616	+6%	+$335K	2.8%	21
2018 Q1	$6.12M	Sell	64,655 -2,622	-4%	-$248K	2.91%	20
2017 Q4	$6.51M	Buy	67,277 +877	+1%	+$84.8K	2.97%	12
2017 Q3	$5.9M	Sell	66,400 -18,066	-21%	-$1.61M	2.98%	10
2017 Q2	$6.13M	Sell	84,466 -5,359	-6%	-$389K	3.06%	2
2017 Q1	$5.85M	Buy	89,825 +19,640	+28%	+$1.28M	3.52%	1
2016 Q4	$4.4M	Buy	70,185 +3,926	+6%	+$246K	2.94%	17
2016 Q3	$4.18M	Buy	66,259 +3,389	+5%	+$214K	3.12%	11
2016 Q2	$3.89M	Buy	62,870 +631	+1%	+$39.1K	3.17%	12
2016 Q1	$3.56M	Buy	62,239 +2,236	+4%	+$128K	2.73%	19
2015 Q4	$3.56M	Buy	60,003 +260	+0.4%	+$15.4K	2.79%	20
2015 Q3	$3.25M	Buy	59,743 +3,565	+6%	+$194K	2.77%	19
2015 Q2	$3.78M	Sell	56,178 -1,824	-3%	-$123K	3.09%	7
2015 Q1	$3.4M	Buy	+58,002	New	+$3.4M	2.8%	20